Pharming (PHAR) Other Non Operating Income (2020 - 2026)

Pharming's Other Non Operating Income history runs 7 years deep, the most recent figure standing at -$2.7 million for Q1 2026.

• Quarterly Other Non Operating Income rose 47.14% year-over-year to -$2.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$28.8 million (down 27.76% YoY) and the FY2025 annual result came in at -$18.1 million, changed N/A from the prior year.
• Other Non Operating Income was -$2.7 million for Q1 2026 at Pharming, up from -$18.1 million in the prior quarter.
• Across five years, Other Non Operating Income topped out at $1.8 million in Q3 2025 and bottomed at -$18.1 million in Q4 2025.
• A 5-year average of -$4.5 million and a median of -$3.0 million in 2024 frame the typical range for Other Non Operating Income.
• Annual changes were most pronounced in 2024 — Other Non Operating Income plunged 220977677.78% — and 2025, when it surged 161.21%.
• Pharming's Other Non Operating Income stood at -$5.5 million in 2022, then soared by 100.0% to -$4.5 in 2023, then plunged by 220977677.78% to -$9.9 million in 2024, then slumped by 82.42% to -$18.1 million in 2025, then soared by 85.14% to -$2.7 million in 2026.
• Business Quant data shows PHAR's Other Non Operating Income at -$2.7 million in Q1 2026, -$18.1 million in Q4 2025, and $1.8 million in Q3 2025.